Podnosis: Digital therapeutics, and how to fix PBMs
Capital Rx Co-Founder & CEO AJ Loiacono joins Frank Diamond for an interview on Fierce's Podnosis podcast. It was a great discussion about everything from drug prices to misaligned incentives in the supply chain, employers' concerns about specialty drug spend, the utility of the national average drug acquisition cost (NADAC) index, and why pharmacy benefit administrators shouldn't be able to mark up and profit from dispensing drugs.
Listen below, starting at the 18:50 mark!
For more information about Capital Rx's full-service pharmacy benefit management (PBM) and administration (PBA) services, please get in touch with us!